JULIE KIDD, Pharm.D., M.P.H., BCPS, CPP (email@example.com), is a Clinical Pharmacy Specialist at Novant Health’s Specialty Pharmacy and works as a Clinical Pharmacist Practitioner (CPP) at Novant Health’s Center for Multiple Sclerosis (MS) in Charlotte, North Carolina. As a CPP, Kidd has created new clinical services in the MS Center to treat and manage symptoms of patients living with MS. Kidd earned her Pharm.D. from Samford University McWhorter School of Pharmacy and completed an ASHP-accredited PGY1 pharmacy residency at the University of Virginia (UVa) Health Systems. She obtained her Master of Public Health (M.P.H.) degree at Oregon Health & Science University (OHSU) while practicing as a clinical pharmacist and serving as PGY1 pharmacy residency Program Coordinator. She has practiced in various roles including acute care, academia, ambulatory care, and specialty pharmacy.
Dr. Kidd has been active with ASHP at both the state and national levels. She completed a six-month traineeship program through ASHP on Patient-Centered Ambulatory Care, was previously involved in the New Practitioners Forum, has served on the Section of Ambulatory Care Practitioners Advisory Group (SAG) on Medication Management Services as well as given webinars and presented podium presentations at ASHP meetings. She currently serves on Section of Specialty Pharmacy Practitioners SAG on Outcomes and Values.
As the newest Section of ASHP, the Section of Specialty Pharmacy Practitioners (SSPP) are in a unique and pivotal time to further develop the field of specialty pharmacy and build resources and connections to colleagues. We have much work to do to overcome barriers, including payer network lockouts, limited-distribution drugs, and other barriers that disrupt the patient journey.
As a practitioner, I have seen first-hand, and believe deeply, that integrated health-system specialty pharmacy is uniquely positioned to provide the best patient care. We are part of the clinical team and have direct access to the medical chart to ensure access and safety of specialty products. We know our patients’ stories and walk with them during this time of disease burden. As we look to the future, the SSPP should continue to measure and publish outcomes-based research in order to demonstrate the value of the services we are providing for our patients facing extremely challenging disease states. ASHP is instrumental to foster collaboration across health-system specialty pharmacy models in order to support and advocate for the work we are doing and leverage new opportunities to take the best care of patients as possible.
I am truly honored to be nominated as Chair of the SSPP, and I will continue the work of demonstrating outcomes-based research to showcase and validate to stakeholders the care we are providing to our patients as health-system specialty pharmacy models. I look forward to working with you all to advance the work of specialty pharmacy practice.